1623 Capital LLC
- SEC CIK
- 0001811034
- Latest filing
- Nov 6, 2025
DXCM holding history
Dexcom Inc in every 13F filed by 1623 Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DXCM overviewAll 13F holders of DXCMFull Q3 2025 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −5,272−100.0% | Sold out | Holders |
| Q3 2022 | 5,272 | $425.0K | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2022 | 5,272 | $393.0K | 0.2% | +1,912+56.9% | AddedConverted for a 4-for-1 split | Holders |
| Q1 2022 | 840 | $430.0K | 0.2% | −324−27.8% | Reduced | Holders |
| Q4 2021 | 1,164 | $625.0K | 0.2% | +179+18.2% | Added | Holders |
| Q3 2021 | 985 | $539.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2021 | 985 | $421.0K | 0.2% | +413+72.2% | Added | Holders |
| Q1 2021 | 572 | $206.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.